Olanzapine affects locomotor activity and meal size in male rats

Pharmacology Biochemistry and Behavior

Volumn 97, Issue 1, 2010, Pages 130-137

  van der Zwaal, Esther M ^a   Luijendijk, Mieneke C M ^a   Evers, Simon S ^b   la Fleur, Susanne E ^a,c   Adan, Roger A H ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Adiposity; Food preference; Locomotor activity; Meal size; Olanzapine; Rat

Indexed keywords

OLANZAPINE;

ANIMAL EXPERIMENT; ARTICLE; BODY COMPOSITION; BODY FAT DISTRIBUTION; BODY TEMPERATURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EXPOSURE; DRUG MECHANISM; ENERGY BALANCE; FOOD INTAKE; FOOD PREFERENCE; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; WEIGHT GAIN; WISTAR RAT;

ADMINISTRATION, ORAL; ANIMALS; BENZODIAZEPINES; EATING; FEEDING BEHAVIOR; INFUSION PUMPS, IMPLANTABLE; MALE; MOTOR ACTIVITY; RATS; RATS, WISTAR; WEIGHT GAIN;

RATTUS;

EID: 77957750470     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2010.05.009     Document Type: Article

References (67)

1. Albaugh, Henry, Bello, Hajnal, Lynch, Halle, et al. Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents. Obesity (Silver Spring) 2006, 14(1):36-51.
2. Aravagiri, Teper, Marder Pharmacokinetics and tissue distribution of olanzapine in rats. Biopharm Drug Dispos 1999, 20(8):369-377.
3. Arjona, Zhang, Adamson, Wurtman An animal model of antipsychotic-induced weight gain. Behav Brain Res 2004, 152(1):121-127.
4. Blass, Chuen Olanzapine-associated hypothermia. Psychosomatics 2004, 45(2):135-139.
5. Blaustein, Wade Ovarian influences on the meal patterns of female rats. Physiol Behav 1976, 17(2):201-208.
6. Bloomfield Changes in musculoskeletal structure and function with prolonged bed rest. Med Sci Sports Exerc 1997, 29(2):197-206.
7. Blouin, Tremblay, Jalbert, Venables, Bouchard, Roy, et al. Adiposity and eating behaviors in patients under second generation antipsychotics. Obesity (Silver Spring) 2008, 16(8):1780-1787.
8. Bromel, Blum, Ziegler, Schulz, Bender, Fleischhaker, et al. Serum leptin levels increase rapidly after initiation of clozapine therapy. Mol Psychiatry 1998, 3(1):76-80.
9. Callaghan, Bergstrom, Ptak, Beasley Olanzapine-pharmacokinetic and pharmacodynamic profile. Clin Pharm 1999, 37(3):177-193.
10. Cooper, Goudie, Halford Acute effects of olanzapine on behavioural expression including the behavioural satiety sequence in female rats. J Psychopharmacol Mar 2009, vol. 0: pp. 0269881109102543v1.
11. Cooper, Harrold, Halford, Goudie Chronic clozapine treatment in female rats does not induce weight gain or metabolic abnormalities but enhances adiposity: implications for animal models of antipsychotic-induced weight gain. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32(2):428-436.
12. Cooper, Pickavance, Wilding, Halford, Goudie A parametric analysis of olanzapine-induced weight gain in female rats. Psychopharmacology (Berl) 2005, 181(1):80-89.
13. Cooper, Pickavance, Wilding, Harrold, Halford, Goudie Effects of olanzapine in male rats: enhanced adiposity in the absence of hyperphagia, weight gain or metabolic abnormalities. J Psychopharmacol 2007, 21(4):405-413
14. Costa e Silva J.A., Alvarez, Mazzotti, Gattaz, Ospina, Larach, et al. Olanzapine as alternative therapy for patients with haloperidol-induced extrapyramidal symptoms: results of a multicenter, collaborative trial in Latin America. J Clin Psychopharmacol 2001, 21(4):375-381.
15. Davoodi, Kalinichev, Korneev, Clifton Hyperphagia and increased meal size are responsible for weight gain in rats treated sub-chronically with olanzapine. Psychopharmacology (Berl) 2009, 203(4):693-702.
16. Eder, Mangweth, Ebenbichler, Weiss, Hofer, Hummer, et al. Association of olanzapine-induced weight gain with an increase in body fat. Am J Psychiatry 2001, 158(10):1719-1722.
17. Fell, Anjum, Dickinson, Marshall, Peltola, Vickers, et al. The distinct effects of subchronic antipsychotic drug treatment on macronutrient selection, body weight, adiposity, and metabolism in female rats. Psychopharmacology (Berl) 2007, 194(2):221-231
18. Fell, Gibson, McDermott, Sisodia, Marshall, Neill Investigation into the effects of the novel antipsychotic ziprasidone on weight gain and reproductive function in female rats. Behav Brain Res 2005, 160(2):338-343.
19. Fell, Marshall, Williams, Neill Effects of the atypical antipsychotic olanzapine on reproductive function and weight gain in female rats. J Psychopharmacol 2004, 18(2):149-155.
20. Fell, Neill, Rao, Marshall Effects of sub-chronic antipsychotic drug treatment on body weight and reproductive function in juvenile female rats. Psychopharmacology 2005, 18(4):499-507.
21. Fukunishi, Sato, Kino, Shirai, Kitaoka Hypothermia in a hemodialysis patient treated with olanzapine monotherapy. J Clin Psychopharmacol 2003, 23(3):314.
22. Gao, Ganocy, Gajwani, Muzina, Kemp, Calabrese A review of sensitivity and tolerability of antipsychotics in patients with bipolar disorder or schizophrenia: focus on somnolence. J Clin Psychiatry 2008, 69(2):302-309.
23. Gebhardt, Haberhausen, Krieg, Remschmidt, Heinzel-Gutenbrunner, Hebebrand, et al. Clozapine/olanzapine-induced recurrence or deterioration of binge eating-related eating disorders. J Neural Transm 2007, 114(8):1091-1095.
24. Gothelf, Falk, Singer, Kairi, Phillip, Zigel, et al. Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic in patients treated with olanzapine. Am J Psychiatry 2002, 159(6):1055-1057.
25. Goudie, Cole, Sumnall Olanzapine withdrawal/discontinuation-induced hyperthermia in rats. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31(7):1500-1503.
26. Goudie, Smith, Halford Characterization of olanzapine-induced weight gain in rats. Psychopharmacol 2002, 16(4):291-296.
27. Graham, Perkins, Edwards, Barrier, Lieberman, Harp Effect of olanzapine on body composition and energy expenditure in adults with first-episode psychosis. Am J Psychiatry 2005, 162(1):118-123.
28. Hartfield, Moore, Clifton Effects of clozapine, olanzapine and haloperidol on the microstructure of ingestive behaviour in the rat. Psychopharmacology 2003, 167(2):115-122.
29. Henderson, Borba, Daley, Boxill, Nguyen, Culhane, et al. Dietary intake profile of patients with schizophrenia. Ann Clin Psychiatry 2006, 18(2):99-105.
30. Hennekens Increasing global burden of cardiovascular disease in general populations and patients with schizophrenia. J Clin Psychiatry 2007, 68(Suppl 4):4-7.
31. Hillebrand, van Elburg Kas, van Engeland Adan Olanzapine reduces physical activity in rats exposed to activity-based anorexia: possible implications for treatment of anorexia nervosa?. Biol Psychiatry 2005, 58(8):651-657.
32. Hung, Huang, Lin Hypothermia and rhabdomyolysis following olanzapine injection in an adolescent with schizophreniform disorder. Gen Hosp Psychiatry 2009, 31(4):376-378.
33. Ishii, Blundell, Halford, Rodgers Palatability, food intake and the behavioural satiety sequence in male rats. Physiol Behav 2003, 80(1):37-47.
34. Jolley Garety, Ellett Kuipers, Freeman Bebbington, Fowler Dunn A validation of a new measure of activity in psychosis. Schizophr Res 2006, 85(1-3):288-295.
35. Kalinichev Rourke, Daniels Grizzle, Britt Ignar, Jones Characterisation of olanzapine-induced weight gain and effect of aripiprazole vs olanzapine on body weight and prolactin secretion in female rats. Psychopharmacology (Berl) 2005, 182(2):220-231.
36. Kalinichev, Rourke, Jones Body weights and plasma prolactin levels in female rats treated subchronically with ziprasidone versus olanzapine. Behav Pharmacol 2006, 17(3):289-292.
37. Kapur, Vanderspek, Brownlee, Nobrega Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy. J Pharmacol Exp Ther 2003, 305(2):625-631.
38. Kassahun Mattiuz, Nyhart Obermeyer, Gillespie Murphy, Goodwin Tupper, Callaghan Lemberger Disposition and biotransformation of the antipsychotic agent olanzapine in humans. Drug Metab Dispos 1997, 25(1):81-93.
39. Kluge Schuld, Himmerich Dalal, Schacht Wehmeier, Hinze-Selch Kraus, Dittmann Pollmacher Clozapine and olanzapine are associated with food craving and binge eating: results from a randomized double-blind study. J Clin Psychopharmacol 2007, 27(6):662-666.
40. Lee, Clifton Meal patterns of free feeding rats treated with clozapine, olanzapine, or haloperidol. Pharmacol Biochem Behav 2002, 71(1-2):147-154.
41. Lehman, Lieberman, Dixon, McGlashan, Miller, Perkins, et al. Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry 2004, 161(2 Suppl):1-56.
42. Leucht Corves, Arbter Engel, Li Davis Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 2009, 373(9657):31-41.
43. Leucht Komossa, Rummel-Kluge Corves, Hunger Schmid, Asenjo Schwarz, Davis A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia. Am J Psychiatry 2009, 166(2):152-163.
44. Levine, Eberhardt, Jensen Role of nonexercise activity thermogenesis in resistance to fat gain in humans. Science 1999, 283(5399):212-214.
45. Lieberman Stroup, McEvoy Swartz, Rosenheck Perkins, Keefe Davis, Davis Lebowitz, Severe Hsiao Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005, 353(12):1209-1223.
46. Minet-Ringuet Even, Goubern Tome, de Beaurepaire Long term treatment with olanzapine mixed with the food in male rats induces body fat deposition with no increase in body weight and no thermogenic alteration. Appetite 2006, 46(3):254-262.
47. Minet-Ringuet Even, Guesdon Tome, de Beaurepaire Effects of chronic neuroleptic treatments on nutrient selection, body weight, and body composition in the male rat under dietary self-selection. Behav Brain Res 2005, 163(2):204-211.
48. Minet-Ringuet Even, Lacroix Tome, de Beaurepaire A model for antipsychotic-induced obesity in the male rat. Psychopharmacology 2006, 187(4):447-454.
49. Musacchia, Steffen, Fell Disuse atrophy of skeletal muscle: animal models. Exerc Sport Sci Rev 1988, 16:61-87.
50. Ninan, Kulkarni Antagonism by pimozide of olanzapine-induced hypothermia. Fundam Clin Pharmacol 1999, 13(5):541-546.
51. Parsons Allison, Loebel Williams, Giller Romano, Siu Weight effects associated with antipsychotics: a comprehensive database analysis. Schizophr Res 2009, 110(1-3):103-110.
52. Perez-Costas Guidetti, Melendez-Ferro Kelley, Roberts Neuroleptics and animal models: feasibility of oral treatment monitored by plasma levels and receptor occupancy assays. J Neural Transm 2008, 115(5):745-753.
53. Pouzet, Mow, Kreilgaard, Velschow Chronic treatment with antipsychotics in rats as a model for antipsychotic-induced weight gain in human. Pharmacol Biochem Behav 2003, 75(1):133-140.
54. Rising Harper, Fontvielle Ferraro, Spraul Ravussin Determinants of total daily energy expenditure: variability in physical activity. Am J Clin Nutr 1994, 59(4):800-804.
55. Roerig Mitchell, de Zwaan Crosby, Gosnell Steffen, Wonderlich A comparison of the effects of olanzapine and risperidone versus placebo on eating behaviors. J Clin Psychopharmacol 2005, 25(5):413-418.
56. Ryan, Thakore Physical consequences of schizophrenia and its treatment: the metabolic syndrome. Life Sci 2002, 71(3):239-257.
57. Scherk, Pajonk, Leucht Second-generation antipsychotic agents in the treatment of acute mania: a systematic review and meta-analysis of randomized controlled trials. Arch Gen Psychiatry 2007, 64(4):442-455.
58. Smith Cornelius, Warnock Bell, Young Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials. Bipolar Disord 2007, 9(4):394-412.
59. Stefanidis Verty, Allen Owens, Cowley Oldfield The role of thermogenesis in antipsychotic drug-induced weight gain. Obesity (Silver Spring) 2009, 17(1):16-24.
60. Strassnig, Brar, Ganguli Nutritional assessment of patients with schizophrenia: a preliminary study. Schizophr Bull 2003, 29(2):393-397.
61. ter Haar Circadian and estrual rhythms in food intake in the rat. Horm Behav 1972, 3(3):213-219.
62. Theisen Linden, Konig Martin, Remschmidt Hebebrand Spectrum of binge eating symptomatology in patients treated with clozapine and olanzapine. J Neural Transm 2003, 110(1):111-121.
63. Thornton-Jones, Neill, Reynolds The atypical antipsychotic olanzapine enhances ingestive behaviour in the rat: a preliminary study. J Psychopharmacol 2002, 16(1):35-37.
64. Thornton-Jones, Kennett, Vickers, Clifton A comparison of the effects of the CB(1) receptor antagonist SR141716A, pre-feeding and changed palatability on the microstructure of ingestive behaviour. Psychopharmacology (Berl) 2007, 193(1):1-9.
65. van der Zwaal, Luijendijk, Adan, la Fleur Olanzapine-induced weight gain: chronic infusion using osmotic minipumps does not result in stable plasma levels due to degradation of olanzapine in solution. Eur J Pharmacol 2008, 585(1):130-136.
66. Victoriano, Hermier, Even, Fromentin, Huneau, Tome, et al. Early perturbation in feeding behaviour and energy homeostasy in olanzapine-treated rats. Psychopharmacology 2009, 206:167-176.
67. Zhang, Yao, Liu, Fang, Reynolds Effects of antipsychotics on fat deposition and changes in leptin and insulin levels. Magnetic resonance imaging study of previously untreated people with schizophrenia. Br J Psychiatry 2004, 184:58-62.